Anti-citrulline antibodies in psoriatic patients with and without arthritis [1]

Acta Dermato-Venereologica

Volumn 85, Issue 3, 2005, Pages 253-254

  Parodi, Aurora ^a   Drosera, Massimo ^a   Seriolo, Bruno ^a   Barbieri, Loris ^b   Rebora, Alfredo ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Bouty SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; BIOCHEMICAL MARKER; CITRULLINE; CITRULLINE ANTIBODY; CYCLOPEPTIDE; UNCLASSIFIED DRUG;

ADULT; ANTIBODY SPECIFICITY; BLOOD SAMPLING; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SKIN MANIFESTATION;

ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CASE-CONTROL STUDIES; CITRULLINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 18844415579     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550410024490     Document Type: Letter

References (8)

1. Schellekens GA, de Jong BAW, van den Hoogen FHJ, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101: 273-281.
2. Schellekens GA, Visser H, de Jong BAW, van den Hoogen FHJ, Hazes JMW, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155-163.
3. Arnett FC, Edworthy SM, Block DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
4. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
5. Nienhuis RLF, Mandena EA. A new serum factor in patients with rheumatoid arthritis. The antiperinuclear factor. Ann Rheum Dis 1964; 23: 302-305.
6. Young BJJ, Mallya RK, Leslie RDG, Clark CJM, Hamblin TJ. Antikeratin antibodies in rheumatoid arthritis. BMJ 1979; 2: 97-99.
7. Sebbag M, Simon M, Vincent C, Masson-Bessière C, Girbal E, Durieux JJ, et al. The perinuclear factor and the socalled antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 1995; 95: 2672-2679.
8. Van Boekel MAM, Vossenaar ER, van den Hoogen FHJ, van Venrooij WJ. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 2002; 4: 87-93.